Blackstone Inc. - ENTASIS THERAPEUTICS HLDGS I ownership

ENTASIS THERAPEUTICS HLDGS I's ticker is ETTX and the CUSIP is 293614103. A total of 18 filers reported holding ENTASIS THERAPEUTICS HLDGS I in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Blackstone Inc. ownership history of ENTASIS THERAPEUTICS HLDGS I
ValueSharesWeighting
Q3 2020$1,159,000
-71.0%
568,004
-57.9%
0.00%
-76.5%
Q2 2020$3,997,000
-6.7%
1,350,490
-16.8%
0.02%
-45.2%
Q1 2020$4,286,000
-46.9%
1,623,4050.0%0.03%
-40.4%
Q4 2019$8,068,000
-16.6%
1,623,4050.0%0.05%
-7.1%
Q3 2019$9,675,000
-7.6%
1,623,4050.0%0.06%
+1.8%
Q2 2019$10,471,000
-4.6%
1,623,4050.0%0.06%
+3.8%
Q1 2019$10,974,000
+66.1%
1,623,4050.0%0.05%
+43.2%
Q4 2018$6,607,0001,623,4050.04%
Other shareholders
ENTASIS THERAPEUTICS HLDGS I shareholders Q1 2019
NameSharesValueWeighting ↓
GARDNER LEWIS ASSET MANAGEMENT L P 1,249,778$2,750,0000.55%
Beryl Capital Management LLC 1,131,772$2,490,0000.26%
DELTEC ASSET MANAGEMENT LLC 155,614$342,0000.08%
Knott David M Jr 41,700$92,0000.04%
TPG GP A, LLC 1,020,748$2,246,0000.04%
GABELLI & Co INVESTMENT ADVISERS, INC. 40,900$90,0000.01%
Ergoteles LLC 135,323$298,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 132,600$292,0000.01%
Virtu Financial LLC 20,027$44,0000.00%
GABELLI FUNDS LLC 59,100$130,0000.00%
View complete list of ENTASIS THERAPEUTICS HLDGS I shareholders